Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Edwards EVOQUE Eos MISCEND Study

NCT: NCT02718001 · ACTIVE_NOT_RECRUITING

NCT IDNCT02718001
StatusACTIVE_NOT_RECRUITING
Start Date2015-02-06
Completion2033-04-30

Brief Summary

Study to evaluate the safety and performance of the Edwards EVOQUE Eos mitral valve replacement system

Frequently Asked Questions

What is Edwards EVOQUE Eos MISCEND Study?

Edwards EVOQUE Eos MISCEND Study is a clinical trial registered under NCT02718001. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT02718001?

The current status of NCT02718001 (Edwards EVOQUE Eos MISCEND Study) is: ACTIVE_NOT_RECRUITING.

When did Edwards EVOQUE Eos MISCEND Study start?

Edwards EVOQUE Eos MISCEND Study started on 2015-02-06.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑